Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin.
Fujiwaki
Takehisa
T
Department of Pediatrics, Matsue Red Cross Hospital, Matsue, Shimane, Japan. take- fujiwaki@k7.dion.ne.jp
Yoshikawa
Tetsushi
T
Urashima
Reiko
R
Ishioka
Chihiro
C
D000667:Ampicillin / Q000009:adverse effects*; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002439:Cefotaxime / Q000009:adverse effects*; D002648:Child; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans
D018926:Anti-Allergic Agents; D000900:Anti-Bacterial Agents; D006634:Histamine H1 Antagonists; D000667:Ampicillin; D002439:Cefotaxime